Comparison of Glutethimide Concentration in the Serum and Cerebrospinal Fluid of Humans in Drug Overdose
Martin Gold, Ernest Tassoni, and Michael Etzl Glutethimide concentrations were measured gas chromatographically in the serum and cerebrospinal fluid(CSF) of patientsin coma caused by overdose of this drug. Piperidionewas used as an internal standard.In the first serum samples collectedfrom each patient, the glutethimideconcentrationranged from 0.9 to 3.1 mg/dl. No patient had a CSF glutethimideconcentrationof more than 0.8 mg/dI. If one excludes patientswho regained consciousness in lessthan 7 h, the seven remaining cases may be described by the following equation:y = 16.06 x106 where y = duration of coma (in h) and x = maximum serum glutethimide concentration (in mg/dl We studied a series of patients in coma due to glutethimide, by sampling their blood stream and lumbar CSF, and report the results here.
Materials and Methods
Venous blood samples were allowed to clot and the serum was removed after centnifugation, the elapsed time being about 45 mm. CSF was removed by lumbar puncture.
The next series of operations were carried out in a 40-ml ground-glass-stoppered centrifuge tube. A Hamilton syringe was used to add 10 IS stands for internal standard, G for glutethimide A standard curve was constructed by adding known concentrations of glutethimide to serum not containing this drug. The peak height ratio (glutethimide/piperidione) and peak area ratio were plotted against the added glutethimide concentrations. A linear relationship was found to exist, at least up to 10 mg/dl serum. REproducibility was better with the peak-height ratio than the peak-area ratio technique.
The areas were measured by peak height times the width at half-height.
All the results presented in this paper were obtained by the former measurement method.
Results
The Both groups found two of these peaks in control sera, so it would appear that the least four peaks in addition to glutethimide are noted in humans.
We have seen up to seven peaks also, but control sera have not demonstrated any corresponding peaks. 
G.B.
IS stands for internal standard, G for glutethimide ide present. Figure 2 shows a compound that appears to be the major metabolite formed, eluting just after glutethimide. It is possible to have all combinations of relative peak heights, depending on when the sample was removed in relation to the time of ingestion.
The longer the time since ingestion, the less glutethimide will be found in the serum compared to the associated peaks, the actual pattern depending on the patient. The CSF patterns of glutethimide concentration tend to follow those found in the serum.
However, the relative peak heights are different. Serum glutethimide levels are graphed against time in Figure  4 . The initial values, at zero time, were the first samples drawn from each patient. This were available and he did not wake up until 82.5 h after the first blood sample.
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It is obvious that his case is unique, as his arousal is so prolonged compared to the other patients. One case (V.D.) had been on L-dopa therapy for severe parkinsonism and this might have had some effect on the results found for the CSF.
Discussion
Possibly the rate of decrease in serum glutethimide was related to the maximal concentration attained in serum. Accordingly, a plot was made of the maximum serum concentration against the rate of decrease found with the succeeding sample for each person. The same procedure was carried out with the CSF specimens.
The results are shown in Figure 6 . There does seem to be a definite relationship. All of the results fall reasonably close to a linear correlation except for one patient whose renal clearance was the greatest of those studied. This was in a 26-yearold girl who had been reported to have had an earlier drug overdose episode.
The CSF values were never above 0.8 mg/dl, and the lowest serum maximum attained was 0.9 mg/dl, so there is no overlapping of results on Figure 6 . It is interesting to note that the rates of change for CSF are similar to what they would be expected to be in serum if there were any serum concentrations corresponding to those in the CSF. 
